Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Trabectedin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 18,282,028Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sonnet Expands SB101 Trial To Test SON-1010-Trabectedin Combo
    Sonnet Expands SB101 Trial To Test SON-1010-Trabectedin Combo

    21 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/21/3012772/0/en/Sonnet-BioTherapeutics-Expands-Phase-1-SB101-Trial-to-Evaluate-Combination-of-SON-1010-with-Trabectedin-in-Certain-Sarcomas.html

    GLOBENEWSWIRE
    21 Jan 2025
    Share Share
    MSN Laboratories' Generic Trabectedin Receives Approval in the U.S.
    MSN Laboratories' Generic Trabectedin Receives Approval in the U.S.

    02 Oct 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216087

    FDA
    02 Oct 2023
    Share Share
    Spain's PharmaMar posts 58% drop in 9-mth profit despite higher revenues
    Spain's PharmaMar posts 58% drop in 9-mth profit despite higher revenues

    28 Oct 2021

    // Anita Kobylinska REUTERS

    https://www.reuters.com/article/us-pharmamar-results/spains-pharmamar-posts-58-drop-in-9-mth-profit-despite-higher-revenues-idUSKBN2HI2DS

    Anita Kobylinska REUTERS
    28 Oct 2021
    Share Share
    PharmaMar signs a licensing agreement with RPharm to commercialize Yondelis®
    PharmaMar signs a licensing agreement with RPharm to commercialize Yondelis®

    24 Dec 2020

    // PRESS RELEASE

    https://pharmamar.com/wp-content/uploads/2020/12/PR_PhM-R-Pharm_agreement_trabectedin_DEF.pdf

    PRESS RELEASE
    24 Dec 2020
    Share Share
    STADA and PharmaMar sign agreement to commercialize Yondelis®
    STADA and PharmaMar sign agreement to commercialize Yondelis®

    17 Nov 2020

    // ZAWYA

    https://www.zawya.com/mena/en/press-releases/story/nbspSTADA_and_PharmaMar_signnbspagreement_to_commercialize_Yondelisregnbsptrabectedin_in_the_MENA_regionnbsp-ZAWYA20201117121507/

    ZAWYA
    17 Nov 2020
    Share Share
    PharmaMar signs a new agreement with Onko to commercialize Yondelis® in Turkey
    PharmaMar signs a new agreement with Onko to commercialize Yondelis® in Turkey

    10 Aug 2020

    // PRESS RELEASE

    http://pharmamar.com/wp-content/uploads/2020/08/PR_PhM_Onko_agreement_DEF.pdf

    PRESS RELEASE
    10 Aug 2020
    Share Share